CME Group Net Profit Margin 2010-2024 | CME
Current and historical net profit margin for CME Group (CME) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. CME Group net profit margin for the three months ending March 31, 2024 was .
| CME Group Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-03-31 |
$5.63B |
$3.16B |
56.12% |
| 2023-12-31 |
$5.58B |
$3.19B |
57.11% |
| 2023-09-30 |
$5.35B |
$3.01B |
56.32% |
| 2023-06-30 |
$5.24B |
$2.94B |
56.17% |
| 2023-03-31 |
$5.12B |
$2.83B |
55.29% |
| 2022-12-31 |
$5.02B |
$2.66B |
52.93% |
| 2022-09-30 |
$4.96B |
$2.63B |
53.10% |
| 2022-06-30 |
$4.84B |
$2.89B |
59.68% |
| 2022-03-31 |
$4.78B |
$2.75B |
57.39% |
| 2021-12-31 |
$4.69B |
$2.62B |
55.81% |
| 2021-09-30 |
$4.64B |
$2.44B |
52.47% |
| 2021-06-30 |
$4.61B |
$1.92B |
41.63% |
| 2021-03-31 |
$4.62B |
$1.91B |
41.45% |
| 2020-12-31 |
$4.88B |
$2.11B |
43.10% |
| 2020-09-30 |
$4.92B |
$2.15B |
43.69% |
| 2020-06-30 |
$5.12B |
$2.38B |
46.40% |
| 2020-03-31 |
$5.21B |
$2.39B |
45.80% |
| 2019-12-31 |
$4.87B |
$2.12B |
43.49% |
| 2019-09-30 |
$4.97B |
$2.03B |
40.91% |
| 2019-06-30 |
$4.59B |
$1.81B |
39.36% |
| 2019-03-31 |
$4.38B |
$1.86B |
42.46% |
| 2018-12-31 |
$4.31B |
$1.96B |
45.52% |
| 2018-09-30 |
$3.97B |
$4.52B |
113.67% |
| 2018-06-30 |
$3.96B |
$4.41B |
111.44% |
| 2018-03-31 |
$3.83B |
$4.26B |
111.45% |
| 2017-12-31 |
$3.65B |
$4.06B |
111.50% |
| 2017-09-30 |
$3.66B |
$1.50B |
40.95% |
| 2017-06-30 |
$3.61B |
$1.66B |
46.05% |
| 2017-03-31 |
$3.59B |
$1.57B |
43.62% |
| 2016-12-31 |
$3.60B |
$1.53B |
42.67% |
| 2016-09-30 |
$3.50B |
$1.45B |
41.56% |
| 2016-06-30 |
$3.50B |
$1.34B |
38.24% |
| 2016-03-31 |
$3.42B |
$1.29B |
37.60% |
| 2015-12-31 |
$3.33B |
$1.25B |
37.48% |
| 2015-09-30 |
$3.35B |
$1.26B |
37.63% |
| 2015-06-30 |
$3.27B |
$1.19B |
36.50% |
| 2015-03-31 |
$3.18B |
$1.19B |
37.48% |
| 2014-12-31 |
$3.11B |
$1.13B |
36.25% |
| 2014-09-30 |
$2.96B |
$1.01B |
34.28% |
| 2014-06-30 |
$2.91B |
$0.96B |
33.01% |
| 2014-03-31 |
$3.00B |
$1.01B |
33.66% |
| 2013-12-31 |
$2.94B |
$0.98B |
33.27% |
| 2013-09-30 |
$2.91B |
$0.95B |
32.67% |
| 2013-06-30 |
$2.88B |
$0.93B |
32.37% |
| 2013-03-31 |
$2.86B |
$0.87B |
30.29% |
| 2012-12-31 |
$2.92B |
$0.90B |
30.77% |
| 2012-09-30 |
$2.99B |
$1.48B |
49.35% |
| 2012-06-30 |
$3.18B |
$1.57B |
49.47% |
| 2012-03-31 |
$3.22B |
$1.62B |
50.34% |
| 2011-12-31 |
$3.28B |
$1.81B |
55.26% |
| 2011-09-30 |
$3.31B |
$1.26B |
38.19% |
| 2011-06-30 |
$3.17B |
$1.19B |
37.62% |
| 2011-03-31 |
$3.14B |
$1.17B |
37.17% |
| 2010-12-31 |
$3.00B |
$0.95B |
31.67% |
| 2010-09-30 |
$2.91B |
$0.96B |
32.94% |
| 2010-06-30 |
$2.83B |
$0.92B |
32.42% |
| 2010-03-31 |
$2.66B |
$0.87B |
32.61% |
| 2009-12-31 |
$2.61B |
$0.83B |
31.61% |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Securities Exchanges |
$76.531B |
$5.579B |
|
CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. CME Group offers a broad range of products covering major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. Trades are executed through CME Group's electronic trading platforms, open outcry and privately negotiated transactions. CME Group also operates one of the world's leading central counterparty clearing providers through CME Clearing and CME Clearing Europe, which offer clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives. Apart from CME and CBOT, the company operates New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX), CME Clearing Europe Limited (CMECE) and CME Europe Limited (CME Europe). The company reports the results of its operations as one operating segment mainly comprised of CME, CBOT, NYMEX and COMEX.
|
